β-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis
- 1 March 2004
- journal article
- research article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 3 (1) , 45-50
- https://doi.org/10.1016/j.jcf.2003.12.008
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Genetic Variants of Human β-Defensin-1 and Chronic Obstructive Pulmonary DiseaseBiochemical and Biophysical Research Communications, 2002
- Identification of a novel, multifunctional *-defensin (human *-defensin 3) with specific antimicrobial activityCell and tissue research, 2001
- Human β‐defensin 4: a novel inducible peptide with a specific salt‐sensitive spectrum of antimicrobial activityThe FASEB Journal, 2001
- Isolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide AntibioticJournal of Biological Chemistry, 2001
- Discovery of new human β-defensins using a genomics-based approachGene, 2001
- Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Bronchoalveolar lavage for the evaluation of anti-inflammatory treatment (BEAT) study groupEuropean Respiratory Journal, 2000
- β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6Science, 1999
- Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.Journal of Clinical Investigation, 1998
- The Human Gene FALL39 and Processing of the Cathelin Precursor to the Antibacterial Peptide LL‐37 in GranulocytesEuropean Journal of Biochemistry, 1996
- Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface FluidCell, 1996